PhRMA spent almost $10 million lobbying to stop legislation to help generic companies
Faced with pressure from President Donald Trump’s administration and lawmakers on drug pricing, generic medicines and trade, the drug industry
Read More
Part D/Prescription Drugs
Panel recommends FDA approval of epilepsy drug derived from marijuana
(By Andrew Joseph for STAT) An expert panel on Thursday unanimously recommended that the Food and Drug Administration approve a new medicine
Read MoreSafety violations at PharMEDium worsen hospital painkiller shortage
(By Megan Knowles for Becker’s Hospital Review) An investigation of PharMEDium, a major compounding pharmacy, revealed safety violations are worsening
Read MoreNation’s Top Doc Wants The Overdose Antidote Widely On Hand. Is That Feasible?
(By Shefali Luthra and Rachel Bluth for Kaiser Health News) When Surgeon General Jerome Adams issued an advisory calling for more people
Read MoreFederal Appeals Court Puts Chill On Maryland Law To Fight Drug Price-Gouging
(By Shefali Luthra for Kaiser Health News) States continue to battle budget-busting prices of prescription drugs. But a federal court
Read MoreCanadian online pharmacy fined for selling counterfeit drugs
United States prosecutors have fined a Canadian online pharmacy $34 million for importing counterfeit drugs and unapproved pharmaceuticals into the
Read MoreInnovative ways to pay for new antibiotics will help fight superbugs
(By Kevin Outterson for STAT) Antibiotics are the most important drug class in human history. Without them, minor infections like
Read MoreFDA Launches Criminal Investigation Into Unauthorized Herpes Vaccine Research
(By Marisa Taylor for Kaiser Health News) The Food and Drug Administration has launched a criminal investigation into research by
Read MoreAetna whistle-blower accuses CVS of ‘spread pricing’ in federal lawsuit
(By Kelly Gooch for Becker’s Hospital Review) CVS Caremark, the pharmacy benefit management division of Woonsocket, R.I.-based CVS Health, stands
Read MoreHow A Drugmaker Turned The Abortion Pill Into A Rare-Disease Profit Machine
(By Sarah Jane Tribble for Kaiser Health News) Even though the $550 yellow pills sold as Korlym have a controversial
Read More